TABLE 4—
Correlates of Viral Suppression on Entry Among Men: Connecticut Department of Corrections, 2005–2012
| Covariate | Model 1, AOR (95% CI) | Model 2, AOR (95% CI) | Model 3, AOR (95% CI) | Model 4, AOR (95% CI) |
| Age (continuous) | 1.06* (1.04, 1.09) | 1.06* (1.04, 1.09) | 1.06* (1.03, 1.08) | 1.05* (1.02, 1.07) |
| Race/ethnicity | ||||
| Non-Hispanic White (Ref) | 1.00 | 1.00 | 1.00 | 1.00 |
| Non-Hispanic Black | 0.31* (0.18, 0.52) | 0.30* (0.18, 0.51) | 0.32* (0.19, 0.53) | 0.35* (0.21, 0.58) |
| Hispanic | 0.35* (0.20, 0.61) | 0.35* (0.20, 0.60) | 0.35* (0.21, 0.61) | 0.37* (0.22, 0.62) |
| Education | ||||
| ≤ high school (Ref) | 1.00 | 1.00 | 1.00 | . . . |
| > high school | 0.84 (0.57, 1.23) | 0.83 (0.37, 1.03) | 0.83 (0.57, 1.21) | . . . |
| CJ risk score | ||||
| Lowest range (Ref) | 1.00 | 1.00 | 1.00 | |
| Middle range | . . . | 0.82 (0.48, 1.41) | 0.75 (0.44, 1.27) | 0.81 (0.47, 1.39) |
| Highest range | . . . | 0.62 (0.37, 1.03) | 0.55* (0.33, 0.92) | 0.49* (0.29, 0.82) |
| Entry ART regimen | ||||
| PI based | . . . | . . . | 0.35 (0.11, 1.13) | |
| nNRTI based | . . . | . . . | 0.47 (0.14, 1.57) | |
| FDC | 0.59 (0.34, 1.00) | 0.63 (0.38, 1.03) | ||
| NRTI only | . . . | . . . | 0.34 (0.10, 1.18) | |
| INSTI | . . . | . . . | 1.27 (0.30, 5.43) | 2.11 (0.87, 5.14) |
| Comorbidity score | . . . | . . . | 1.11* (1.00, 1.24) | 1.13* (1.01, 1.26) |
| Incarceration period by intake year | ||||
| 2005–2007 (Ref) | . . . | . . . | . . . | 1.00 |
| 2008–2010 | . . . | . . . | . . . | 2.13* (1.52, 2.97) |
| 2011–2012 | . . . | . . . | . . . | 2.83* (1.74, 4.58) |
| Medical insurance on entry | ||||
| Yes (Ref) | . . . | . . . | . . . | 1.00 |
| No | . . . | . . . | . . . | 0.56 (0.31, 1.03) |
| AIC/BIC | 1815.79/1844.06 | 1815.77/1853.46 | 1806.90/1872.86 | 1788.45/1835.57 |
Note. AOR = adjusted odds ratio; AIC = Akaike information criterion; ART = antiretroviral therapy; BIC = Bayesian information criterion; CI = confidence interval; CJ = criminal justice; DOT = directly observed therapy; FDC = fixed-dose combination; INSTI = integrase strand transfer inhibitor; nNRTI = nonnucleoside reverse transcriptase inhibitor; NRTI = nucleoside reverse transcriptase inhibitor; PI = protease inhibitor; SAT = self-administered therapy. Model 1 includes demographic characteristics only (age, race/ethnicity, education); model 2 includes demographics and CJ risk; model 3 includes demographics, CJ risk, and HIV and other comorbidity severity; model 4 includes all covariates for which P < .1 on bivariate association, followed by stepwise selection. The sample size was n = 824 individuals and n = 1532 incarceration periods.
*P < .05.